Cargando…

Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy

PURPOSE: To evaluate the effect of extraretinal proliferative vitreoretinopathy (PVR) on retinal shortening in eyes with rhegmatogenous retinal detachment (RD) using ultrasound (USG) and objectively prove the presence of intraretinal PVR (iPVR). METHODS: This is a double-masked pilot prospective con...

Descripción completa

Detalles Bibliográficos
Autores principales: Takkar, Brijesh, Temkar, Shreyas, Gaur, Nripen, Venkatesh, Pradeep, Chawla, Rohan, Kumar, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700587/
https://www.ncbi.nlm.nih.gov/pubmed/29133645
http://dx.doi.org/10.4103/ijo.IJO_481_17
_version_ 1783281153317273600
author Takkar, Brijesh
Temkar, Shreyas
Gaur, Nripen
Venkatesh, Pradeep
Chawla, Rohan
Kumar, Atul
author_facet Takkar, Brijesh
Temkar, Shreyas
Gaur, Nripen
Venkatesh, Pradeep
Chawla, Rohan
Kumar, Atul
author_sort Takkar, Brijesh
collection PubMed
description PURPOSE: To evaluate the effect of extraretinal proliferative vitreoretinopathy (PVR) on retinal shortening in eyes with rhegmatogenous retinal detachment (RD) using ultrasound (USG) and objectively prove the presence of intraretinal PVR (iPVR). METHODS: This is a double-masked pilot prospective controlled case series. Patients with total RD planned for vitreoretinal surgery were included in the study. USG was used to determine retinal-to-choroidal length ratios (RCRs) in all the quadrants. Group 1 included 10 patients with preoperative PVR more than Grade B while Group 2 had 14 with PVR of Grades A or B. Severe retinal shortening was defined as RCR < 0.8. Primary outcome measures were severe retinal shortening and an early unexplained recurrence of RD within 15 days of surgery. RESULTS: Mean RCRs were significantly low in all the four quadrants of Group 1 upon comparison with Group 2. The mean RCR had a good negative correlation with number of quadrants of PVR (R = −0.66, P ≤ 0.001). Overall, severe quadrantic retinal shortening was detected in nine patients. In these 9 patients, 11 of the 36 retinal quadrants had severe retinal shortening in the absence of extraretinal PVR (ePVR). Six patients developed early unexplained RD, and all of these belonged to Group 1. Severe quadrantic retinal shortening had the highest odds ratio of developing early unexplained RD (odds ratio = 58, P = 0.01). CONCLUSION: Retinal shortening occurs both due to ePVR and iPVR, and iPVR occurs independently at least in some cases. Severe quadrantic retinal shortening indicates poor primary anatomical prognoses.
format Online
Article
Text
id pubmed-5700587
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-57005872017-12-01 Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy Takkar, Brijesh Temkar, Shreyas Gaur, Nripen Venkatesh, Pradeep Chawla, Rohan Kumar, Atul Indian J Ophthalmol Original Article PURPOSE: To evaluate the effect of extraretinal proliferative vitreoretinopathy (PVR) on retinal shortening in eyes with rhegmatogenous retinal detachment (RD) using ultrasound (USG) and objectively prove the presence of intraretinal PVR (iPVR). METHODS: This is a double-masked pilot prospective controlled case series. Patients with total RD planned for vitreoretinal surgery were included in the study. USG was used to determine retinal-to-choroidal length ratios (RCRs) in all the quadrants. Group 1 included 10 patients with preoperative PVR more than Grade B while Group 2 had 14 with PVR of Grades A or B. Severe retinal shortening was defined as RCR < 0.8. Primary outcome measures were severe retinal shortening and an early unexplained recurrence of RD within 15 days of surgery. RESULTS: Mean RCRs were significantly low in all the four quadrants of Group 1 upon comparison with Group 2. The mean RCR had a good negative correlation with number of quadrants of PVR (R = −0.66, P ≤ 0.001). Overall, severe quadrantic retinal shortening was detected in nine patients. In these 9 patients, 11 of the 36 retinal quadrants had severe retinal shortening in the absence of extraretinal PVR (ePVR). Six patients developed early unexplained RD, and all of these belonged to Group 1. Severe quadrantic retinal shortening had the highest odds ratio of developing early unexplained RD (odds ratio = 58, P = 0.01). CONCLUSION: Retinal shortening occurs both due to ePVR and iPVR, and iPVR occurs independently at least in some cases. Severe quadrantic retinal shortening indicates poor primary anatomical prognoses. Medknow Publications & Media Pvt Ltd 2017-11 /pmc/articles/PMC5700587/ /pubmed/29133645 http://dx.doi.org/10.4103/ijo.IJO_481_17 Text en Copyright: © 2017 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Takkar, Brijesh
Temkar, Shreyas
Gaur, Nripen
Venkatesh, Pradeep
Chawla, Rohan
Kumar, Atul
Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
title Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
title_full Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
title_fullStr Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
title_full_unstemmed Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
title_short Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
title_sort retinal shortening: ultrasonic evaluation of proliferative vitreoretinopathy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700587/
https://www.ncbi.nlm.nih.gov/pubmed/29133645
http://dx.doi.org/10.4103/ijo.IJO_481_17
work_keys_str_mv AT takkarbrijesh retinalshorteningultrasonicevaluationofproliferativevitreoretinopathy
AT temkarshreyas retinalshorteningultrasonicevaluationofproliferativevitreoretinopathy
AT gaurnripen retinalshorteningultrasonicevaluationofproliferativevitreoretinopathy
AT venkateshpradeep retinalshorteningultrasonicevaluationofproliferativevitreoretinopathy
AT chawlarohan retinalshorteningultrasonicevaluationofproliferativevitreoretinopathy
AT kumaratul retinalshorteningultrasonicevaluationofproliferativevitreoretinopathy